Rheumatoid arthritis (RA): Nursing process (ADPIE)

Last updated: February 19, 2026

Rheumatoid arthritis (RA): Nursing process (ADPIE)

Watch later

Watch later

Infection prevention and control - Precautions and personal protective equipment (PPE): Nursing skills
Urinary tract infections (UTIs): Nursing process (ADPIE)
Modes of infectious disease transmission
Epstein-Barr virus (Infectious mononucleosis)
Pneumonia
Wound healing
Palliative and hospice care: Nursing
Postoperative care: Nursing
Biology of cancer: Nursing
Biliary atresia: Nursing
Cholecystitis: Nursing
Cholelithiasis: Nursing
Colorectal cancer: Nursing
Diarrhea: Nursing
Diverticular disease: Nursing
Esophageal cancer: Nursing
Gastric cancer: Nursing
Hepatitis: Nursing
Inflammatory bowel disease - Crohn disease and ulcerative colitis: Nursing
Intestinal obstruction: Nursing
Irritable bowel syndrome (IBS): Nursing
Jaundice: Nursing
Laryngeal cancer: Nursing
Liver cancer: Nursing
Pancreatic cancer: Nursing
Esophageal atresia and tracheoesophageal fistula: Nursing
Geriatric considerations - Gastrointestinal: Nursing
Hirschsprung disease: Nursing
Hyperemesis gravidarum: Nursing
Necrotizing enterocolitis: Nursing
Omphalocele and gastroschisis: Nursing
Appendicitis: Nursing process (ADPIE)
Celiac disease: Nursing process (ADPIE)
Cirrhosis: Nursing process (ADPIE)
Gastroesophageal reflux disease (GERD): Nursing process (ADPIE)
Hiatal hernia: Nursing process (ADPIE)
Pancreatitis: Nursing process (ADPIE)
Peptic ulcer disease (PUD): Nursing process (ADPIE)
Antacids: Nursing pharmacology
Antidiarrheals: Nursing pharmacology
Antiemetics: Nursing pharmacology
Antispasmodics (GI): Nursing pharmacology
Gallstone-dissolving agents: Nursing pharmacology
Gastric mucosal protective agents: Nursing pharmacology
Histamine H2 antagonists: Nursing pharmacology
Laxatives: Nursing pharmacology
Medications for hepatic encephalopathy: Nursing pharmacology
Pancreatic enzyme replacements: Nursing pharmacology
Proton pump inhibitors (PPIs): Nursing pharmacology
Treatment for Helicobacter pylori: Nursing pharmacology
Weight loss medications: Nursing pharmacology
Bladder tumors: Nursing
Chronic kidney disease (CKD): Nursing
Dialysis care: Nursing
Epididymitis: Nursing
Glomerulonephritis: Nursing
Nephrotic syndrome: Nursing
Polycystic kidney disease (PKD): Nursing
Prostate cancer: Nursing
Pyelonephritis: Nursing
Renal and urinary calculi: Nursing
Renal cancer: Nursing
Testicular cancer: Nursing
Urinary retention: Nursing
Bladder exstrophy: Nursing
Circumcision: Nursing
Cryptorchidism: Nursing
Enuresis: Nursing
Geriatric considerations - Urinary: Nursing
Hypospadias and epispadias: Nursing
Acute kidney injury (AKI): Nursing process (ADPIE)
Benign prostatic hyperplasia (BPH): Nursing process (ADPIE)
Urinary incontinence - Stress: Nursing process (ADPIE)
Antispasmodics (GU): Nursing pharmacology
Cholinergic therapy (GU): Nursing pharmacology
Diuretics - Osmotic and carbonic anhydrase inhibitors: Nursing pharmacology
Diuretics - Thiazide, thiazide-like, loop, and potassium-sparing diuretics: Nursing pharmacology
Anemia - Aplastic: Nursing
Anemia - Iron-deficiency: Nursing
Anemia - Macrocytic: Nursing
Arterial blood gas (ABG) - Overview: Nursing
Arterial blood gas (ABG) - Metabolic acidosis: Nursing
Arterial blood gas (ABG) - Metabolic alkalosis: Nursing
Arterial blood gas (ABG) - Respiratory acidosis: Nursing
Arterial blood gas (ABG) - Respiratory alkalosis: Nursing
Blood cultures: Nursing
Cardiac biomarkers - Creatine kinase (CK): Nursing
Cardiac biomarkers - Troponin: Nursing
Coagulation studies - Partial thromboplastin time (PTT): Nursing
Complete blood count (CBC) - Hemoglobin and hematocrit: Nursing
Complete blood count (CBC) - Platelets: Nursing
Complete blood count (CBC) - Red blood cells (RBC): Nursing
Complete blood count (CBC) - White blood cells (WBC) and differential: Nursing
Complete metabolic panel (CMP) - Blood urea nitrogen (BUN) and creatinine (Cr): Nursing
Complete metabolic panel (CMP) - Chloride: Nursing
Complete metabolic panel (CMP) - Estimated glomerular filtration rate (eGFR): Nursing
Complete metabolic panel (CMP) - Glucose: Nursing
Complete metabolic panel (CMP) - Liver function tests (LFT): Nursing
Complete metabolic panel (CMP) - Potassium: Nursing
Complete metabolic panel (CMP) - Sodium: Nursing
Complete metabolic panel (CMP) - Total protein: Nursing
Disseminated intravascular coagulation (DIC): Nursing
Multiple myeloma: Nursing
Neutropenia: Nursing
Polycythemia: Nursing
Thalassemia: Nursing
Thrombocytopenia: Nursing
Leukemia: Nursing process (ADPIE)
Anticoagulants - Direct thrombin and factor Xa inhibitors: Nursing pharmacology
Anticoagulants - Heparin: Nursing pharmacology
Anticoagulants - Warfarin: Nursing pharmacology
Antihyperlipidemics - Bile acid sequestrants and cholesterol absorption inhibitors: Nursing pharmacology
Antihyperlipidemics - Fibrates: Nursing pharmacology
Antihyperlipidemics - Miscellaneous: Nursing pharmacology
Antihyperlipidemics - Statins: Nursing pharmacology
Antiplatelet agents: Nursing pharmacology
Blood products: Nursing pharmacology
Hematopoietic growth factors: Nursing pharmacology
Hemostatics: Nursing pharmacology
Iron preparations: Nursing pharmacology
Thrombolytics: Nursing pharmacology
Autoimmunity: Nursing
Human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS): Nursing
Hypersensitivity reactions - Type I: Nursing
Hypersensitivity reactions - Type II: Nursing
Hypersensitivity reactions - Type III: Nursing
Hypersensitivity reactions - Type IV: Nursing
Immune response - Adaptive: Nursing
Immune response - Innate: Nursing
Immunodeficiency disorders - Primary: Nursing
Immunodeficiency disorders - Secondary: Nursing
Inflammatory process: Nursing
Scleroderma: Nursing
Shock - Anaphylactic: Nursing
Sjögren syndrome: Nursing
Systemic lupus erythematosus (SLE): Nursing
Toxic shock syndrome (TSS): Nursing
Erythema infectiosum (Fifth disease): Nursing
Fever: Nursing
Infectious mononucleosis: Nursing
Mumps (Parotitis): Nursing
Neonatal sepsis: Nursing
Pertussis: Nursing
Poliomyelitis: Nursing
Postpartum infections: Nursing
Roseola (Exanthem subitum): Nursing
Rubella (German measles): Nursing
Rubeola (Measles): Nursing
Smallpox: Nursing
Zika virus: Nursing
Anaphylaxis: Nursing process (ADPIE)
Lyme disease: Nursing process (ADPIE)
Rheumatoid arthritis (RA): Nursing process (ADPIE)
Antirejection immunosuppressants: Nursing pharmacology
Biologic agents: Nursing pharmacology
Disease-modifying therapy for multiple sclerosis: Nursing pharmacology
Immunoglobulins: Nursing pharmacology
Immunomodulators: Nursing pharmacology
Immunosuppressants for autoimmune diseases: Nursing pharmacology
Non-biologic disease-modifying antirheumatic drug (DMARD) therapy: Nursing pharmacology
Vaccines: Nursing pharmacology
Acne: Nursing
Animal and snake bites: Nursing
Burn injury: Nursing
Cutaneous fungal infections: Nursing
Erysipelas and cellulitis: Nursing
Folliculitis, carbuncles, and furuncles: Nursing
Herpes simplex virus (HSV): Nursing
Herpes zoster: Nursing
Impetigo: Nursing
Insect stings and bites: Nursing
Pediculosis and scabies: Nursing
Psoriasis: Nursing
Rocky Mountain spotted fever (RMSF): Nursing
Skin cancer - Basal cell carcinoma, squamous cell carcinoma, and melanoma: Nursing
Urticaria: Nursing
Geriatric considerations - Integumentary: Nursing
Atopic dermatitis: Nursing process (ADPIE)
Frostbite: Nursing process (ADPIE)
Methicillin-resistant Staphylococcus aureus (MRSA): Nursing process (ADPIE)
Pressure injury: Nursing process (ADPIE)
Antibiotics - Topical: Nursing pharmacology
Antifungals - Topical: Nursing pharmacology
Corticosteroids - Topical: Nursing pharmacology
Debridement agents: Nursing pharmacology
Keratolytics: Nursing pharmacology
Medications for acne vulgaris: Nursing pharmacology
Osteoarthritis: Nursing
Osteomyelitis: Nursing
Osteoporosis: Nursing
Hip fractures: Nursing
Developmental dysplasia of the hip: Nursing
Acute compartment syndrome: Nursing process (ADPIE)
Fractures: Nursing process (ADPIE)
Gout: Nursing process (ADPIE)
Musculoskeletal injuries: Nursing process (ADPIE)
Buerger disease: Nursing
Raynaud phenomenon: Nursing
Peripheral arterial disease (PAD): Nursing process (ADPIE)
Peripheral venous disease (PVD): Nursing process (ADPIE)
Atelectasis: Nursing
Geriatric considerations - Respiratory: Nursing
Venous thromboembolism (VTE): Nursing process (ADPIE)
Asthma: Nursing process (ADPIE)
Bacterial pneumonia: Nursing process (ADPIE)
Bronchiolitis and respiratory syncytial virus (RSV): Nursing process (ADPIE)
Carbon monoxide poisoning: Nursing process (ADPIE)
Chronic obstructive pulmonary disease (COPD): Nursing process (ADPIE)
Epiglottitis: Nursing process (ADPIE)
Foreign body aspiration and upper airway obstruction: Nursing process (ADPIE)
Laryngotracheobronchitis (LTB) and croup: Nursing process (ADPIE)
Smoke inhalation injury: Nursing process (ADPIE)
Papulosquamous and inflammatory skin disorders: Pathology review

Notes

RHEUMATOID ARTHRITIS

KEY POINTS
NOTES
PATIENT REPORT
  • 44-year-old 
  • Presents to clinic reporting pain, stiffness, and swelling in bilateral hands
  • Pain worse in morning
  • General fatigue
  • Decreased appetite

PATHOPHYSIOLOGY
  • Chronic autoimmune inflammatory disorder 
  • Primarily affects joints 
  • Can involve skin, lungs, and other organs 
  • Causes 
    • Genetic and environmental interaction 
    • Associated with HLA-DR4 gene 
  • Risk factors 
    • Family history 
    • Biological female sex 
    • Middle age 
    • Obesity 
    • Infections
    • Smoking
    • Asbestos
    • Silica exposure 
  • Pathophysiology 
    • Environmental triggers modify body proteins 
    • Modified proteins become antigens 
    • Immune system produces autoantibodies: 
    • Rheumatoid factor (RF) targets IgG 
    • Anti-CCP targets citrullinated proteins 
    • Antibodies and immune cells enter joints 
    • Cytokines cause inflammation and synovial proliferation 
    • Formation of pannus (thickened synovial tissue) 
    • Cartilage damage and bone erosion 
    • Immune complexes activate complement system 
    • Articular manifestations 
      • Symmetric and progressive joint involvement 
      • Pain, swelling, and reduced mobility 
      • Morning stiffness improves after 30 minutes 
      • Commonly affects 
        • Proximal interphalangeal and metacarpophalangeal joints 
        • Metatarsophalangeal joints in feet 
        • Shoulders, elbows, wrists, knees, ankles 
        • Hips 
        • C1-C2 joint  
    • Extra-articular manifestations 
      • Fever, fatigue, weakness, appetite loss, weight loss 
      • Vasculitis and atheromatous plaques 
      • Risk of myocardial infarction or stroke 
      • Muscle inflammation and breakdown 
      • Rheumatoid nodules on bony prominences 
      • Carpal tunnel syndrome 
      • Pulmonary fibrosis and pleural effusion 
      • Increased risk of osteoporosis

DIAGNOSIS AND TREATMENT
  • Diagnosis
    • History
    • Physical assessment
    • Laboratory tests
    • Diagnostic imaging
  • Treatment
    • First-line treatment 
      • Disease-modifying antirheumatic drugs (DMARDs)
        • Non-biological DMARDs 
        • Biological DMARDs 
    • Symptom relief 
      • Glucocorticoids 
      • NSAIDs
    • Encourage regular exercise 
    • Promote smoking cessation

ASSESSMENT
  • Subjective symptoms
    • Pain in both hands, especially knuckles 
    • Difficulty with daily tasks  
    • Morning stiffness improves after 30 minutes 
    • Afternoon fatigue and poor evening appetite 
    • Unintentional weight loss  
  • Physical assessment 
    • Height: 5 feet 5 inches 
    • Weight: 110 pounds 
    • Temperature: 99℉ or 37.2℃ 
    • Heart rate: 88 beats per minute 
    • Respiratory rate: 14 breaths per minute 
    • Blood pressure: 122/80 mmHg 
    • SpO2: 98% on room air 
    • Pain 6/10 
      • Swollen and tender hand joints on palpation 
  • Laboratory findings 
    • RBCs: 4 million/mm³ (4.0 x 1012/L)
    • Hemoglobin: 12 g/dL (120 g/L)
    • Hematocrit: 36% 
    • ESR: 25 mm/h 
    • CRP: 12 mg/L 
    • RF: 25 IU/mL 
    • Anti-CCP: 59 EU/mL

NURSING DIAGNOSES
  • Chronic pain related to joint inflammation
  • Imbalanced nutrition: less than body requirements related to lack of appetite and unintentional weight loss
  • Activity intolerance related to chronic pain and fatigue
  • Readiness for enhanced coping related to a new diagnosis 

PLANNING
  • By follow-up visit patient will
    • Report a decrease in pain
    • Have met with a registered dietitian to formulate a plan to increase nutritional intake and maintain a healthy weight
    • Report increased tolerance for activity and increased ability to do activities of daily living
    • Verbalize an understanding of rheumatoid arthritis management
    • Demonstrate effective coping strategies

IMPLEMENTATION
  • Prescribed ibuprofen for pain and inflammation 
  • Prescribed DMARD 
  • Prescribed folic acid  
  • Advised to avoid alcohol while on methotrexate 
  • Informed about need for periodic lab monitoring 
  • Instructed to report symptoms like
    • Upset stomach 
    • Unusual fatigue 
    • Easy bruising 
  • Health promotion and lifestyle modifications
    • Encouraged rest periods
    • Scheduled appointment with registered dietician 
    • Referred to physical therapy 
    • Provided information on local rheumatoid arthritis support group 

EVALUATION
  • Patient reports less fatigue overall 
  • Pain and swelling in joints have decreased 
  • Current pain rating 3/10 
  • Attends weekly physical therapy sessions 
  • Improved flexibility and strength 
  • Appetite has improved 
  • Eating a balanced diet with dietician’s help 
  • Gained 2 lbs (0.9 kg)
  • Made friends in support group 
  • Feels more optimistic about diagnosis 

Transcript

Watch video only

Clara Reed is a 44-year-old female client who presents to the rheumatology clinic after being referred by her primary care physician. For the past several weeks, she has been having pain, stiffness and swelling in both hands along with stiffness in her body that is worse in the morning. She has also been feeling fatigued and her appetite has decreased.

Alright, so rheumatoid arthritis is a chronic, autoimmune, inflammatory disorder that mostly affects the joints, but can also involve other organ systems like the skin and lungs. This condition is typically triggered by an interaction between genetic and environmental factors. Rheumatoid arthritis tends to run in families and it’s been associated with the HLA-DR4 gene.  Other risk factors include being female, middle aged, and obese.  Finally environmental factors like infections, smoking, and   exposure to asbestos and silica are also linked to the disease.

A person with the HLA–DR4 gene, might develop rheumatoid arthritis after getting exposed to something in the environment like cigarette smoke or a specific pathogen. These environmental factors can cause modification of the proteins in our body and turn them into antigens that trigger the immune system to produce specific autoantibodies against them. 

The first antibody  is called rheumatoid factor, or RF, and targets modified IgG antibodies; whereas the second antibody is called anti-cyclic citrullinated peptide antibody or anti-CCP, and targets citrullinated proteins, like citrullinated collagen II. 

Next, these antibodies and immune cells enter the circulation and reach joints. Here, immune cells release inflammatory cytokines that induce inflammation and stimulate synovial cells to proliferate. Increased number of synovial and immune cells in the joint creates a pannus, which is a thick synovial membrane with granulation tissue. 

Over time, the cytokines released in the pannus start to damage the articular cartilage, leaving the underlying bone exposed. As a result, bones start to directly rub against one another, eventually causing bone erosion. Meanwhile, the antibodies that enter the joint space bind to their targets and form immune complexes that accumulate in the synovial fluid, activating the complement system and inducing further destruction of the joint.

Now, rheumatoid arthritis is a symmetric and progressive condition, associated with articular and extra-articular manifestations. Articular manifestations include pain, swelling, and loss of mobility in the affected joints. Also, there's no redness or warmth because the inflammatory process is gradual, but there’s morning stiffness that typically improves after 30 minutes of movement. 

Most commonly, rheumatoid arthritis affects the proximal interphalangeal and metacarpophalangeal joints of the hand. Distal interphalangeal joints are rarely involved because they have very little synovium. In the feet, the metatarsophalangeal joints are usually affected, which causes a person to bear more weight on the heels and hyperextend the toes. 

Other joints that can be involved are the shoulders, elbows, wrists, knees, and ankles. Hip involvement can occur later in the disease, and it’s characterized by pain in the groin, thigh, or lower back. Finally, if rheumatoid arthritis affects the C1-C2 joint, which is the only synovial joint in the spine, it can cause quadriplegia, which is the loss of use of all extremities. 

On the flip side, extra-articular symptoms include fever, fatigue, weakness, and a loss of appetite that can eventually lead to weight loss. 

Rheumatoid arthritis can also lead to vasculitis and the formation of atheromatous plaques, which can break off and cause myocardial infarction or stroke. In fact, cardiovascular disease is the main cause of mortality in individuals with rheumatoid arthritis. 

In skeletal muscle, inflammation can lead to muscle breakdown, and in the skin, inflammation can cause the formation of rheumatoid nodules over bony prominences. 

Rheumatoid arthritis is also associated with carpal tunnel syndrome, which refers to the compression of the median nerve on its way through the wrist, through a narrow passageway called the carpal tunnel

In the lungs, clients might develop pulmonary fibrosis or scarring of the lung tissue, and pleural effusion, which is an accumulation of fluid in the pleural space. Finally, the destruction of bones and skeletal system increases the risk of osteoporosis

Diagnosis is based on clinical examination and blood tests, which typically reveal low red blood cell count, in combination with elevated erythrocyte sedimentation rate, or ESR and C-reactive protein, often referred to as CRP. Moreover, these findings are commonly seen in conditions associated with chronic inflammation. Additionally, these clients should be tested for rheumatoid factor and anti-cyclic citrullinated peptide antibodies.

Sources

  1. "Global, regional, and national burden of rheumatoid arthritis, 1990-2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021" Lancet Rheumatol (2023)
  2. "Update on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis" Cells (2020)
  3. "Harrison’s Principles of Internal Medicine, 21st edition" McGraw Hill / Medical (2022)
  4. "Robbins & Kumar Basic Pathology, 11th edition" Elsevier (2022)
  5. "Pathogenesis of rheumatoid arthritis: one year in review 2022" Clin Exp Rheumatol (2022)
  6. "Management of Rheumatoid Arthritis: An Overview" Cells (2021)
  7. "The etiology of rheumatoid arthritis" J Autoimmun (2020)